Sun Pharma loses over 3.5% in today’s trade
DSIJ Intelligence / 14 Aug 2017
With its weak Q1FY18 figures, pharmaceutical major Sun Pharmaceutical Industries lost over 3.5% in the early morning trade today.
With its weak Q1FY18 figures, pharmaceutical major Sun Pharmaceutical Industries lost over 3.5% in the early morning trade today. The company’s revenue for the quarter was Rs 6,167 crore, posting 23% YoY decline. The EBITDA for the quarter fell by 53.2% YoY to Rs 1,400 crore and there was a net loss of Rs 321 crore as against net profit of Rs 2,268 crore in Q1FY17. This was due to a one-time exceptional provision of Rs 950 crore for settlements with Apotex Corporation and retail purchasers.
Sun Pharma was trading at Rs 437.90 per share, down by Rs 437.90 or 2.97% as at 0918 hours on Monday, on the BSE. The stock attracted a traded volume of 19,82,456 shares and traded value of Rs 8,693.66 lakh on the NSE.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.